Table 2.
Demographic and Laboratory Data in MDS Subgroups and AML-MDS Group
| Parameter | Group I (n=24) | Group II (n=16) | Group III (n=6) | P value |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| Sex (N & %): | ||||
| Female | 10 (41.7%) | 7 (43.8%) | 3 (50%) | P=0.1 |
| Male | 14 (58.3%) | 9 (56.2%) | 3 (50%) | |
| Age | 57.8±7.2 | 60.5±5.8 | 62.7±3.6 | P=0.1 |
| TNF alpha(ng/ml) | 8.7±0.8 | 10.5±1.5 | 12.0±0.8 | P≤0.001 |
| IL32 (ng/ml) | 5.5±1.7 | 8.96±1.7 | 11.1±1.9 | P≤0.001 |
| Total lymphocytes count ×103/cmm | 574.4±178.5 | 451.9±99.6 | 398.3±122.9 | P≤0.001 |
| T lymphocytes (Percentage of total lymphocytes) | 82.1±7.1 | 80.1±4.97C | 74.7±4.8 | P≤0.001 |
| NK (Percentage of total lymphocytes) | 11.8±5.1 | 8.7±2.3 | 5.8±3.4A | P≤0.001 |
| Mature NK (Percentage of total NK) | 83.7±6.1 | 84.6±3.7 | 85.7±1.7C | P>0.05 |
MET, Monte Carlo exact test; A, B, C, significant difference between the corresponding group by Bonferroni's post hoc multiple comparison